Stryker (TICKER: SYK) Benchmark And Performance Data

there are 11 of samples in the benchmark for Stryker in year 2022 in 2022. The total inventory for Stryker was $3,494,000,000.00 in 2020. The total inventory for Stryker was $3,314,000,000.00 in 2021. The total inventory for Stryker was $2,980,000,000.00 in 2019. The total inventory for Stryker was $2,955,000,000.00 in 2018. The total inventory for Stryker was $2,465,000,000.00 in 2017. The total inventory for Stryker was $2,030,000,000.00 in 2016. The total inventory for Stryker was $1,639,000,000.00 in 2015. The total inventory for Stryker was $1,588,000,000.00 in 2014. The total inventory for Stryker was $1,422,000,000.00 in 2013. The total inventory for Stryker was $1,265,000,000.00 in 2012. The sales, general, and administrative (SGA) for Stryker was $6,427,000,000.00 in 2021. The sales, general, and administrative (SGA) for Stryker was $5,361,000,000.00 in 2020. The sales, general, and administrative (SGA) for Stryker was $5,356,000,000.00 in 2019. The sales, general, and administrative (SGA) for Stryker was $5,099,000,000.00 in 2018. The sales, general, and administrative (SGA) for Stryker was $4,552,000,000.00 in 2017. The sales, general, and administrative (SGA) for Stryker was $4,137,000,000.00 in 2016. The sales, general, and administrative (SGA) for Stryker was $3,610,000,000.00 in 2015. The sales, general, and administrative (SGA) for Stryker was $3,547,000,000.00 in 2014. The sales, general, and administrative (SGA) for Stryker was $3,467,000,000.00 in 2013. The sales, general, and administrative (SGA) for Stryker was $3,367,000,000.00 in 2012. The sales, general, and administrative (SGA) for Stryker was $$6,455,000,000 in 2022. The revenue volatility for Stryker was 11.56% in 2022. The market capitalization for Stryker was $99,485,721,723.00 in 2013. The market capitalization for Stryker was $97,943,214,726.00 in 2012. The market capitalization for Stryker was $92,522,333,341.00 in 2018. The market capitalization for Stryker was $76,647,197,819.00 in 2017. The market capitalization for Stryker was $75,259,338,044.00 in 2016. The market capitalization for Stryker was $115,866,555,140.00 in 2020. The market capitalization for Stryker was $108,366,743,148.00 in 2019. The market capitalization for Stryker was $103,782,010,302.00 in 2021. The market capitalization for Stryker was $101,099,493,288.00 in 2015. The market capitalization for Stryker was $100,951,050,000.00 in 2014. The market capitalization for Stryker was $$116,926,000,000 in 2022. The gross revenue for Stryker was $9,946,000,000.00 in 2015. The gross revenue for Stryker was $9,675,000,000.00 in 2014. The gross revenue for Stryker was $9,021,000,000.00 in 2013. The gross revenue for Stryker was $8,657,000,000.00 in 2012. The gross revenue for Stryker was $17,108,000,000.00 in 2021. The gross revenue for Stryker was $14,884,000,000.00 in 2019. The gross revenue for Stryker was $14,351,000,000.00 in 2020. The gross revenue for Stryker was $13,601,000,000.00 in 2018. The gross revenue for Stryker was $12,444,000,000.00 in 2017. The gross revenue for Stryker was $11,325,000,000.00 in 2016. The gross revenue for Stryker was $$18,449,000,000 in 2022. The gross margin for Stryker was $16.49% in 2022. The days sales outstanding for Stryker was 65 days in 2022. The days payable outstanding for Stryker was 68 days in 2022. The days of inventory for Stryker was $194 in 2022. The cost of goods sold (COGS) for Stryker was 37.24% in 2022. The cost of goods sold (COGS) for Stryker was $6,140,000,000.00 in 2021. The cost of goods sold (COGS) for Stryker was $5,294,000,000.00 in 2020. The cost of goods sold (COGS) for Stryker was $5,188,000,000.00 in 2019. The cost of goods sold (COGS) for Stryker was $4,663,000,000.00 in 2018. The cost of goods sold (COGS) for Stryker was $4,264,000,000.00 in 2017. The cost of goods sold (COGS) for Stryker was $3,821,000,000.00 in 2016. The cost of goods sold (COGS) for Stryker was $3,344,000,000.00 in 2015. The cost of goods sold (COGS) for Stryker was $3,319,000,000.00 in 2014. The cost of goods sold (COGS) for Stryker was $3,002,000,000.00 in 2013. The cost of goods sold (COGS) for Stryker was $2,781,000,000.00 in 2012. The cost of goods sold (COGS) for Stryker was $$6,871,000,000 in 2022. The cash to cash cycle time for Stryker was 191 in 2022. The annual percentage growth rate of Stryker was -0.08% in 2022. Stryker in its benchmark peer group, had rank 8 for sales growth in 2022. Stryker in its benchmark peer group, had rank 8 days for days sales outstanding in 2022. Stryker in its benchmark peer group, had rank 8 days for days of inventory in 2022. Stryker in its benchmark peer group, had rank 7 for cash to cash cycle time in 2022. Stryker in its benchmark peer group, had rank 6 for cost of goods sold as a percent of revenue in 2022. Stryker in its benchmark peer group, had rank 2 for gross revenue in 2022. Stryker headquarters region is Central. Stryker has ticker symbol SYK. Stryker has the following profile: Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies.. Stryker has primary indstury Medical Devices. Stryker had a $$0 gap between actual performance and next performance rank for gross revenue in competitive benchmarking in 2022. Stryker had Abbott Laboratories, and QuidelOrtho, and Zimmer Biomet, and Edwards Lifesciences, and Bio-Rad Laboratories, and Boston Scientific, and Align Technology, and Stryker, and AdaptHealth, and Bruker, and DexCom benchmark peer companies for its SIC code in 2022. Stryker had 53 days gap between actual performance and next performance rank for cash to cash in competitive benchmarking in 2022. Stryker had 51,000 number of employees in 2022. Stryker had 5.68% gap between actual performance and next performance rank for cost of goods sold as a percent of revenue in competitive benchmarking in 2022. Stryker had 5 days gap between actual performance and next performance rank for days sales outstanding in competitive benchmarking in 2022. Stryker had 35 days gap between actual performance and next performance rank for days of inventory in competitive benchmarking in 2022. Stryker had 1.67% gap between actual performance and next performance rank for sales volatility in competitive benchmarking in 2022. Stryker had 0.69% gap between actual performance and next performance rank for gross margin in competitive benchmarking in 2022. Stryker had 0.03% gap between actual performance and next performance rank for sales growth in competitive benchmarking in 2022. Stryker can reduce overall cost by $$2,053,000,000 by improving both COGS and SGA to next benchmark tier in 2022. Stryker can reduce inventory with practices including SKU Reduction in 2022. Stryker can reduce inventory with practices including Reduce Manufacturing Latency in 2022. Stryker can reduce inventory with practices including Forecast Accuracy in 2022. Stryker can reduce inventory with practices including Demand Shaping in 2022. Stryker can reduce days sales outstanding with practices including in 2022. Stryker can increase sales revenue by $$0 improving sales performance to next benchmark tier in 2022. Stryker can increase revenue growth by $$6,000,000 by improving growth performance to next benchmark tier in 2022. Stryker can increase overall revenue by $$6,000,000 by improving both growth and sales performance to next benchmark tier in 2022. Stryker can increase days payables outstanding with practices including Strategic Sourcing in 2022. Stryker can increase days payables outstanding by $404,000,000 days by increasing days payables outstanding to next benchmark tier in 2022. Stryker can improve total financial performance by $$4,485,000,000 by improving revenue, costs, and working capital in 2022. Stryker can decrease overall working capital by $$2,426,000,000 by improving inventory, payables and receivables to next benchmark tier in 2022. Stryker can decrease inventory days by $1,769,000,000 days by reducing inventory days to next benchmark tier in 2022. Stryker can decrease days sales outstanding by $253,000,000 days by reducing days sales outstanding to next benchmark tier in 2022. Stryker can accelerate revenue growth practices including Revenue-optimized Planning in 2022. Stryker can accelerate revenue growth practices including Pricing Optimization in 2022. Stryker can accelerate revenue growth practices including Accelerate Design Pipeline in 2022. 94 days was the measured superior or top ten performance level for days of inventory in Stryker's peer group in 2022. 9.89% was the measured superior or top ten performance level for sales volatility in Stryker's peer group in 2022. 75 days was the measured superior or top ten performance level for cash to cash cycle time in Stryker's peer group in 2022. 60 days was the measured parity or middle performance level for days sales outstanding in Stryker's peer group in 2022. 53 days was the measured advantage or top third performance level for days sales outstanding in Stryker's peer group in 2022. 44 days was the measured superior or top ten performance level for days sales outstanding in Stryker's peer group in 2022. 37.24% was the measured parity or middle performance level for cost of goods sold as a percent of revenue in Stryker's peer group in 2022. 31.56% was the measured advantage or top third performance level for cost of goods sold as a percent of revenue in Stryker's peer group in 2022. 30.00% was the measured superior or top ten performance level for gross margin in Stryker's peer group in 2022. 29.10% was the measured superior or top ten performance level for cost of goods sold as a percent of revenue in Stryker's peer group in 2022. 159 days was the measured parity or middle performance level for days of inventory in Stryker's peer group in 2022. 138 days was the measured parity or middle performance level for cash to cash cycle time in Stryker's peer group in 2022. 13.32% was the measured parity or middle performance level for sales volatility in Stryker's peer group in 2022. 119 days was the measured advantage or top third performance level for cash to cash cycle time in Stryker's peer group in 2022. 11.40% was the measured advantage or top third performance level for sales volatility in Stryker's peer group in 2022. 108 days was the measured advantage or top third performance level for days of inventory in Stryker's peer group in 2022. 0.04% was the measured superior or top ten performance level for sales growth in Stryker's peer group in 2022. -0.05% was the measured parity or middle performance level for sales growth in Stryker's peer group in 2022. -0.02% was the measured advantage or top third performance level for sales growth in Stryker's peer group in 2022. $18.02% was the measured advantage or top third performance level for gross margin in Stryker's peer group in 2022. $17.18% was the measured parity or middle performance level for gross margin in Stryker's peer group in 2022. $$6,940,000,000 was the measured advantage or top third performance level for gross revenue in Stryker's peer group. $$3,735,000,000 was the measured parity or middle performance level for gross revenue in Stryker's peer group in 2022. $$18,449,000,000 was the measured superior or top ten performance level for gross revenue in Stryker's peer group in 2022.